Drug Eluting Balloon for Treatment of Unstable Angina

Drug Eluting Balloon Combined With Cutting Balloon for Treatment of Unstable Angina

This study was to investigate the effect and safety of drug eluting balloon combined for treatment of unstable angina.

Patients with unstable angina were randomized to drug eluting stent only or drug eluting balloon group. Angiographic follow-up was performed after 12 months. The primary endpoints were late lumen loss (LLL) and the secondary endpoints were target lesion revascularization (TLR),and the major adverse cardiovascular events (MACE) .

Inclusion Criteria:

• Patients > 18, < 80 years old, with unstable angina
• Single-vessel or double-vessel disease
• Length of target lesion < 25mm
• Diameter of target vessel >2.5mm, < 3.5mm

Exclusion Criteria:

• Left main disease
• Chronic total occlusion
• Severe Tortuosity
• Heavy calcification
• Severe liver failure, moderate or severe kidney failure
• Malignant disease
• Active infectious disease
• Pregnancy or breastfeeding